These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2470064)

  • 1. Substance P antagonist-induced spinal cord vasoconstriction: effects of thyrotropin-releasing hormone and substance P agonists.
    Helke CJ; Phillips ET
    Peptides; 1988; 9(6):1307-15. PubMed ID: 2470064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoconstrictor effects in spinal cord of the substance P antagonist [D-Arg, D-Trp7,9 Leu11]-substance P (Spantide) and somatostatin and interaction with thyrotropin releasing hormone.
    Freedman J; Post C; Kåhrström J; Ohlen A; Mollenholt P; Owman C; Alari L; Hökfelt T
    Neuroscience; 1988 Oct; 27(1):267-78. PubMed ID: 2462190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action.
    Helke CJ; Phillips ET; O'Neill JT
    J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do local vasomotor effects elicit the motor deficits induced by intrathecally applied substance P antagonists in the rat?
    Barber A; Wild A; Wedel R
    Neurosci Lett; 1987 Sep; 80(2):219-23. PubMed ID: 2446208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional peripheral and CNS hemodynamic effects of intrathecal administration of a substance P receptor agonist.
    Helke CJ; Phillips ET; O'Neill JT
    J Auton Nerv Syst; 1987 Nov; 21(1):1-7. PubMed ID: 2450116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord.
    Akagi H; Konishi S; Otsuka M; Yanagisawa M
    Br J Pharmacol; 1985 Mar; 84(3):663-73. PubMed ID: 2580581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone.
    Freedman J; Hökfelt T; Post C; Brodin E; Sundström E; Jonsson G; Terenius L; Leander S; Fischer JA; Verhofstad A
    Exp Brain Res; 1989; 74(2):279-92. PubMed ID: 2466686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LH-RH analogue acts as substance P antagonist by inhibiting spinal cord vasomotor responses.
    Takano Y; Sawyer WB; Sanders NL; Loewy AD
    Brain Res; 1985 Jul; 337(2):357-61. PubMed ID: 2411337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist.
    Freedman J; Hökfelt T; Jonsson G; Post C
    Exp Brain Res; 1986; 62(1):175-8. PubMed ID: 2420632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRH fails to antagonize the acute paralytic effects of intrathecal dynorphin A and substance P antagonists in the rat.
    Martinez-Arizala A; Long JB; Holaday JW
    Brain Res; 1988 Nov; 473(2):385-8. PubMed ID: 2466528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P antagonist inhibits vasomotor responses elicited from ventral medulla in rat.
    Loewy AD; Sawyer WB
    Brain Res; 1982 Aug; 245(2):379-83. PubMed ID: 6181849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of substance P analogues on spinal dorsal horn neurons.
    Randic M; Jeftinija S; Urban L; Raspantini C; Folkers K
    Peptides; 1988; 9(3):651-60. PubMed ID: 2458574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of slow excitatory post-synaptic potential by substance P antagonists in guinea-pig sympathetic ganglia.
    Konishi S; Otsuka M
    J Physiol; 1985 Apr; 361():115-30. PubMed ID: 2580973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis.
    Couture R; Gupta A; Kérouac R; Escher E; Regoli D
    Can J Physiol Pharmacol; 1987 Mar; 65(3):412-8. PubMed ID: 2438022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of substance P release from the intermediate area of rat thoracic spinal cord.
    Yang L; Thomas ND; Helke CJ
    Synapse; 1996 Aug; 23(4):265-73. PubMed ID: 8855511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing gastric motor responses to TRH and substance P on their microinjection into nucleus raphe obscurus of rats.
    Krowicki ZK; Hornby PJ
    Am J Physiol; 1993 Nov; 265(5 Pt 1):G819-30. PubMed ID: 7694501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intrathecal proctolin administration on the behaviour evoked by the thyrotrophin-releasing hormone (TRH) analogue (RX 77368) and the indoleamine, TRH, substance P and calcitonin gene-related peptide levels and choline acetyltransferase activity in the rat spinal cord.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Brain Res; 1988 Sep; 460(1):22-8. PubMed ID: 2464406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.